Structural variations in the central heterocyclic scaffold of tripartite 2,6-difluorobenzamides: influence on their antibacterial activity against mdr staphylococcus aureus

HIGHLIGHTS

• who: Thibaut Barbier et al. from the , Villeurbanne, France have published the article: Structural Variations in the Central Heterocyclic Scaffold of Tripartite 2,6-Difluorobenzamides: Influence on Their Antibacterial Activity against MDR Staphylococcus aureus, in the Journal: Molecules 2022, 6619 of /2022/
• what: The aim of this experiment was to establish the minimum inhibS. aureus, including a reference (ATCC 29213) and two clinically isolated strains respectively of S. concentration aureus, a reference (ATCC 29213) and two to clinically strains tively resistant to (MIC), methicillin (SF8300) and daptomycin (ST20171643) ,respecwith PC190723 as including control.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.